None
EN
KFF Health Tracking Poll: Mifepristone and the Midterms
['.Wp-Block-Kff-Shared-Authors Align-Items Center Display Flex Gap Var', '.Wp-Block-Kff-Shared-Authors__Title Flex-Shrink Font-Size Var --Fs-Body-Md', 'Font-Weight Var --Fw-Bold', 'Line-Height Var --Lh-M', '.Wp-Block-Kff-Shared-Authors__List Display Flex Flex-Wrap Wrap', 'Media', 'Min-Width', '.Wp-Block-Kff-Shared-Authors__List Gap Var', '.Wp-Block-Kff-Shared-Authors__List.Wp-Block-Kff-Shared-Authors__List--Show-Seperators Gap Var', '.Wp-Block-Kff-Shared-Authors__List.Wp-Block-Kff-Shared-Authors__List--Show-Seperators .Wp-Block-Kff-Shared-Authors__Seperator Display Block']
KFF
Four in ten Democratic voters say abortion policy is “extremely important” for 2026 midterm candidates to talk about, compared to fewer independent (22%) and Republican (20%) voters.
The latest KFF Health Tracking Poll finds six in ten (60%) adults have heard of the abortion medication mifepristone, including two-thirds (66%) of women of reproductive age (ages 18 to 49).
Similar shares of adults overall say abortion pills are safe compared to last year (42% in November 2025).
The latest KFF Health Tracking Poll finds majorities oppose laws that would place further restrictions on medication abortion.
In contrast, fewer independent (22%) and Republican (20%) voters say abortion policy is extremely important for midterm candidates to discuss.